Exelixis
EXEL
#2031
Rank
HK$60.98 B
Marketcap
HK$213.78
Share price
3.65%
Change (1 day)
25.22%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: HK$60.98 Billion

As of September 2024 Exelixis has a market cap of HK$60.98 Billion. This makes Exelixis the world's 2031th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024HK$60.98 B4.66%
2023HK$58.26 B44.13%
2022HK$40.42 B-10.36%
2021HK$45.09 B-6.59%
2020HK$48.27 B15.78%
2019HK$41.69 B-9.72%
2018HK$46.18 B-34.27%
2017HK$70.26 B109.63%
2016HK$33.52 B236.4%
2015HK$9.96 B355.3%
2014HK$2.18 B-75.05%
2013HK$8.77 B34.81%
2012HK$6.50 B30.52%
2011HK$4.98 B-28.59%
2010HK$6.98 B13.19%
2009HK$6.16 B50.13%
2008HK$4.10 B-41.77%
2007HK$7.05 B5%
2006HK$6.71 B10.3%
2005HK$6.09 B22.14%
2004HK$4.98 B27.81%
2003HK$3.90 B5.31%
2002HK$3.70 B-49.08%
2001HK$7.27 B36.51%
2000HK$5.33 B

End of Day market cap according to different sources

On Sep 15th, 2024 the market cap of Exelixis was reported to be:

HK$58.83 Billion
by Yahoo Finance info icon info icon
HK$58.83 Billion
by CompaniesMarketCap info icon info icon
HK$58.83 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
HK$691.95 B 1,034.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$1.121 T 1,738.65%๐Ÿ‡ซ๐Ÿ‡ท France
HK$2.338 T 3,734.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$791.92 B 1,198.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.404 T 2,202.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.126 T 5,026.48%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.327 T 2,076.34%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.27 B-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.06 B-93.33%๐Ÿ‡บ๐Ÿ‡ธ USA